High insulin-like growth factor binding protein 1 levels in cirrhosis: Link with insulin resistance

Hepatology

Volumn 24, Issue 1, 1996, Pages 127-133

  Shmueli, Ehoud ^a,c   Miell, John P ^b   Stewart, Murray ^a   Alberti, K George M M ^a   Record, Christopher O ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0029994141     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008707251     Document Type: Article

References (32)

1. Møller N, Jørgensen JOL, Schmitz O, Moller J, Christiansen JS, Alberti KGMM, Orskov H, et al. Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol 1990;258:E86-E91.
2. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131-53.
3. Zenobi PD, Graf S, Ursprung H, Froesch ER. Effects of insulin-like growth factor on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest 1992;89:1908-1913.
4. Lee PDK, Conover CA, Powell DR. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exper Biol Med 1993;204:4-29.
5. Shmueli E, Walker M, Alberti KGMM, Record CO. Normal splanchnic but impaired peripheral insulin stimulated glucose uptake in cirrhosis. HEPATOLOGY 1993; 18:86-95.
6. Shmueli E, Stewart M, Alberti KGMM, Record CO. Growth hormone, IGF-I, and insulin resistance in cirrhosis. HEPATOLOGY 1994; 19:322-328.
7. Levy JC, Brown G, Matthews DR, Turner RC. Hepatic glucose output in humans measured with labelled glucose to reduce negative errors. Am J Physiol 1989;257:E531-E540.
8. Ader M, Bergman RN. Insulin sensitivity in the intact organism. Baillieres Clin Endocrinol Metab 1987;1:879-910.
9. Harrison J, Hodson AW, Skillen AW, Stappenbeck R, Agius L, Alberti KGMM. Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acetoacetate measurements in man using a centrifugal analyser with a fluorimetric attachment. J Clin Chem Clin Biochem 1988;26:141-146.
10. Knox DP, Jones DG. Automated enzymatic determination of plasma free fatty acids by centrifugal analysis. J Automatic Chem 1984;6:152-154.
11. Soeldner JS, Slone D. Critical variables in the radioimmunoassay of serum insulin using the double-antibody technique. Diabetes 1965;14:771-779.
12. Ørskov H, Thomsen HG, Yde H. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 1968; 219:193-195.
13. Miell JP, Taylor AM, Zini M, Maheshwari H, Ross RJM, Valcavi R. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone (GH) and IGFBPs. J Clin Endocrinol Metab 1993;76:950-955.
14. Taylor AM, Dunger DB, Preece MA, Holly JMP, Smith CP, Wass JAH, Patel S, Tate VE, et al. The growth hormone independent insulin-like growth factor binding protein, BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin dependent diabetics. Clin Endo 1990;32:229-239.
15. Zillikens MC, van den Berg JWO, Wilson JHP, Rietveld T, Swart GR. The validity of bioelectrical impedance analysis in estimating total body water in patients with cirrhosis. J Hepatol 1992;16:59-65.
16. Bang P, Brismar K, Rosenfeld RG, Hall K. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects. J Clin Endocrinol Metab 1994;78:960-967.
17. Lewit MS, Denyer GS, Cooney GJ, Baxter RC. Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology 1991; 129: 2254-2256.
18. Caro JF, Poulos J, Ittoop O, Pories WJ, Flickinger EG, Sinha MK. Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest 1988;81:976-981.
19. Pinzani M, Abboud HE, Aron DC. Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: regulatory role of platelet derived growth factor. Endocrinology 1990;127:2343-2349.
20. Mohn KL, Melby AE, Tewari DS, Laz TM, Taub R. The gene encoding insulin-like growth factor-binding protein 1 is rapidly and highly induced in regenerating liver. Mol Cell Biol 1991;11:1393-1401.
21. Lee J, Greenbaum L, Haber BA, Nagle D, Lee V, Miles V, Mohn KL, et al. Structure and localization of the IGFBP-1 gene and its expression during liver regeneration. HEPATOLOGY 1994;19:656-665.
22. Ren SG, Ezzat S, Melmed S, Braunstein GL. Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells. Endocrinology 1992;131:2479-2481.
23. Bratusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 1982;55:973-982.
24. Rizza RA, Mandarino LJ, Gerich JE. Effects of growth hormone on insulin action in man. Diabetes 1982;31:663-669.
25. Fryburg DA, Louard RJ, Gerow KE, Gelfand RA, Barrett EJ. Growth hormone stimulates muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes 1992;41:424-429.
26. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty acid cycle. Lancet 1963;i:785-789.
27. Slootweg MC, De Groot RP, Herrmann-Erlee MPN, Koornneep I, Kruijer W, Kramer YK. Growth hormone induces expression of c-jun and jun-B oncogenes and employs protein kinase C signal transduction for the induction of the c-fos oncogene expression. J Mol Endocrinol 1991;6:179-188.
28. Shmueli E, Alberti KGMM, Record CO. Hypothesis - diacylglycerol and protein kinase C signalling: a mechanism for insulin resistance. J Intern Med 1993;234:397-400.
29. Yan Z, Biggs RB, Booth FW. Insulin-like growth factor immunoreactivity increases in muscle after acute eccentric contractions. J Appl Physiol 1993; 74:410-414.
30. Ernst M, Rodan GA. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH induced IGF-binding protein BP-3. Endocrinology 1990;127:807-814.
31. Lee PDQ, Suwanichkul A, Depaolis LA, Snuggs MB, Morris SL, Powell DR, et al. IGF suppression of IGFBP-1 production - evidence for mediation by the type 1 IGF receptor. Regul Pept 1993;48:199-206.
32. Thrailkill KM, Clemmons DR, Busby WH, Handwerger S. Differential regulation of IGFBP secretion from human decidual cells by IGF-I. J Clin Invest 1990;86:878-883.